866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Non-steroidal Anti-inflammatory Drugs(NSAID) Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 119 Pages

In this report, the EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Non-steroidal Anti-inflammatory Drugs(NSAID) for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) market competition by top manufacturers/players, with Non-steroidal Anti-inflammatory Drugs(NSAID) sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer
Novacap
Abbott
Pfizer
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
Glaxo Smith Kline
Reddy Pharmaceuticals
Johnson & Johnson

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Non-steroidal Anti-inflammatory Drugs(NSAID) for each application, including
Back Pain Treatment
Osteoarthritis Treatment
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Non-steroidal Anti-inflammatory Drugs(NSAID) Market Report 2017
1 Non-steroidal Anti-inflammatory Drugs(NSAID) Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs(NSAID)
1.2 Classification of Non-steroidal Anti-inflammatory Drugs(NSAID)
1.2.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Nabumetone
1.2.7 Others
1.3 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market by Application/End Users
1.3.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Back Pain Treatment
1.3.3 Osteoarthritis Treatment
1.3.4 Other
1.4 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market by Region
1.4.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Non-steroidal Anti-inflammatory Drugs(NSAID) (2012-2022)
1.5.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2022)
1.5.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate (2012-2022)

2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Competition by Players/Manufacturers
2.1.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Share by Players (2012-2017)
2.1.3 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sale Price by Players (2012-2017)
2.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) (Volume and Value) by Type/Product Category
2.2.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sale Price by Type (2012-2017)
2.3 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) (Volume) by Application
2.4 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) (Volume and Value) by Region
2.4.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Price by Region (2012-2017)

3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Value (2012-2017)
3.1.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate (2012-2017)
3.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Type
3.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Application
3.4 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume by Countries (2012-2017)
3.4.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries (2012-2017)
3.4.3 Germany Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
3.4.4 France Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
3.4.5 UK Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
3.4.6 Russia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
3.4.7 Italy Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
3.4.8 Benelux Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)

4 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Value (2012-2017)
4.1.1 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate (2012-2017)
4.2 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Type
4.3 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Application
4.4 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume by Countries (2012-2017)
4.4.2 Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
4.4.4 Israel Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
4.4.5 UAE Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
4.4.6 Iran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)

5 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Value (2012-2017)
5.1.1 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate (2012-2017)
5.2 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Type
5.3 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Market Share by Application
5.4 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume by Countries (2012-2017)
5.4.2 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries (2012-2017)
5.4.3 South Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
5.4.5 Egypt Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)
5.4.6 Algeria Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate (2012-2017)

6 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers/Players Profiles and Sales Data
6.1 Bayer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novacap
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Abbott
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Geri-Care Pharmaceuticals
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Perrigo Company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Kopran
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Merck Sharp & Dohme
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sun Pharmaceutical Industries
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Glaxo Smith Kline
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Reddy Pharmaceuticals
6.12 Johnson & Johnson

7 Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturing Cost Analysis
7.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs(NSAID)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs(NSAID) Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Forecast (2017-2022)
11.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Price and Trend Forecast (2017-2022)
11.2 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Type (2017-2022)
11.7 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Non-steroidal Anti-inflammatory Drugs(NSAID)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume Market Share by Type (Product Category) in 2016
Figure Aspirin Product Picture
Figure Ibuprofen Product Picture
Figure Naproxen Product Picture
Figure Nabumetone Product Picture
Figure Others Product Picture
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Non-steroidal Anti-inflammatory Drugs(NSAID) by Application in 2016
Figure Back Pain Treatment Examples
Figure Osteoarthritis Treatment Examples
Figure Other Examples
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size (Million USD) by Region (2012-2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume and Growth Rate (2012-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Players (2012-2017)
Figure 2016 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Players
Figure 2017 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Players
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) by Players (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Players (2012-2017)
Table 2016 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Players
Table 2017 EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Players
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs(NSAID) by Type (2012-2017)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs(NSAID) by Type in 2016
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs(NSAID) by Application (2012-2017)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application in 2016
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Share by Region (2012-2017)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs(NSAID) by Region (2012-2017)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in 2016
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs(NSAID) by Region (2012-2017)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share Regions in 2016
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) by Type (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Type (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Type in 2016
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) by Application (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Application (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Application in 2016
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) by Countries (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Countries (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Countries (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Countries in 2016
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) by Countries (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries (2012-2017)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries in 2016
Figure Germany Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure France Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure UK Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) by Type (2012-2017)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Type (2012-2017)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Type (2012-2017)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) by Applications (2012-2017)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Market Share by Applications (2012-2017)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application in 2016
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume Market Share by Countries in 2016
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) by Countries (2012-2017)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries (2012-2017)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries (2012-2017)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) by Type (2012-2017)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Type in 2016
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) by Application (2012-2017)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Application (2012-2017)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Volume (K MT) by Countries (2012-2017)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Countries (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Countries (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Countries in 2016
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) by Countries (2012-2017)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries (2012-2017)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share by Countries in 2016
Figure South Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Table Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate (2012-2017)
Figure Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share in EMEA (2012-2017)
Figure Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share in EMEA (2012-2017)
Table Reddy Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Johnson & Johnson Non-steroidal Anti-inflammatory Drugs(NSAID) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs(NSAID)
Figure Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs(NSAID)
Figure Non-steroidal Anti-inflammatory Drugs(NSAID) Industrial Chain Analysis
Table Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs(NSAID) Major Manufacturers in 2016
Table Major Buyers of Non-steroidal Anti-inflammatory Drugs(NSAID)
Table Distributors/Traders List
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share Forecast by Region (2017-2022)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share Forecast by Region (2017-2022)
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share Forecast by Countries (2017-2022)
Table Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share Forecast by Countries (2017-2022)
Table Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share Forecast by Type (2017-2022)
Table EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *